These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8510782)

  • 21. In vitro chloroquine resistant Plasmodium falciparum in Calcutta and its sensitivity to qinghaosu (artemisitene).
    Sinha S; Choudhury DS; Ghosh SK; Devi CU; Sharma VP
    Indian J Malariol; 1987 Dec; 24(2):107-9. PubMed ID: 3330710
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of alpha-beta arteether in clearing Plasmodium falciparum parasitemia in central India (Madhya Pradesh).
    Singh N; Shukla MM; Asthana OP; Sharma VP
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):225-7. PubMed ID: 9886102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naphthoquine phosphate and its combination with artemisinine.
    Wang JY; Cao WC; Shan CQ; Zhang M; Li GF; Ding DB; Shi YL; Wu BA
    Acta Trop; 2004 Feb; 89(3):375-81. PubMed ID: 14744564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasmodium falciparum hematozoan morphological alterations in Gabon children treated with artemether].
    Kombila M; Duong T; Dufillot D; Koko J; Guiyedi V; Guiguen C; Richard-Lenoble D
    Med Trop (Mars); 1995; 55(4 Suppl):97-100. PubMed ID: 8649280
    [No Abstract]   [Full Text] [Related]  

  • 25. Presumptive artemether resistance in a patient with mixed malarial infection.
    Sharma P; Kumar A; Pant P; Prakash S
    J Assoc Physicians India; 2003 Feb; 51():233. PubMed ID: 12725279
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combination therapy as a strategy to prevent antimalarial drug resistance].
    Orjuela P; González I; Osorio L
    Biomedica; 2004 Dec; 24(4):423-37. PubMed ID: 15678806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of alpha,beta-arteether in acute falciparum malaria.
    Mishra SK; Asthana OP; Mohanty S; Patnaik JK; Das BS; Srivastava JS; Satpathy SK; Dash S; Rath PK; Varghese K
    Trans R Soc Trop Med Hyg; 1995; 89(3):299-301. PubMed ID: 7660441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the gametocytocidal/sporontocidal action of qinghaosu (artemisinin) by electron microscopy.
    Dutta GP; Mohan A; Tripathi R
    J Parasitol; 1990 Dec; 76(6):849-52. PubMed ID: 2254819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine.
    Murphy S; Watkins WM; Bray PG; Lowe B; Winstanley PA; Peshu N; Marsh K
    Am J Trop Med Hyg; 1995 Sep; 53(3):303-5. PubMed ID: 7573718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
    Na-Bangchang K; Congpuong K; Sirichaisinthop J; Suprakorb K; Karbwang J
    Br J Clin Pharmacol; 1997 Jun; 43(6):639-42. PubMed ID: 9205825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current data on major novel antiamalaria drugs: Artemisinin (qinghaosu) derivatives].
    Ambroise-Thomas P
    Bull Acad Natl Med; 1999; 183(4):797-80; discussion 810-3. PubMed ID: 10437302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies on the treatment of malaria with qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
    J Tradit Chin Med; 1982 Mar; 2(1):45-50. PubMed ID: 6765847
    [No Abstract]   [Full Text] [Related]  

  • 33. Artemisinin antimalarials: mechanisms of action and resistance.
    Meshnick SR
    Med Trop (Mars); 1998; 58(3 Suppl):13-7. PubMed ID: 10212891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu).
    Doury JC; Ringwald P; Guelain J; Le Bras J
    Trop Med Parasitol; 1992 Sep; 43(3):197-8. PubMed ID: 1470842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rediscovering wormwood: qinghaosu for malaria.
    Lancet; 1992 Mar; 339(8794):649-51. PubMed ID: 1347342
    [No Abstract]   [Full Text] [Related]  

  • 37. Bogus antimalarials: a forgotten tale.
    Reithinger R
    Trends Parasitol; 2001 Aug; 17(8):359. PubMed ID: 11685892
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.
    Wongsrichanalai C; Sirichaisinthop J; Karwacki JJ; Congpuong K; Miller RS; Pang L; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):41-9. PubMed ID: 11485094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action.
    Cumming JN; Ploypradith P; Posner GH
    Adv Pharmacol; 1997; 37():253-97. PubMed ID: 8891104
    [No Abstract]   [Full Text] [Related]  

  • 40. Artemisinine and its derivatives.
    Gera R; Khalil A
    Indian Pediatr; 1997 Sep; 34(9):813-6. PubMed ID: 9492419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.